Figures & data
FIG. 1 Cyclophosphamide Inhibition of the Antibody Response to sRBC from a Representative Laboratory. Dose response curves for percent inhibition were plotted in Microsoft Excel, a best-fitting trendline drawn, and the dose of each compound to inhibit the response (AFC: Antibody Forming Cell/106 splenocytes; AFC spleen: AFC/spleen; ELISA) by 50% (ID50) in rats (R) or mice (M) was visually determined.
![FIG. 1 Cyclophosphamide Inhibition of the Antibody Response to sRBC from a Representative Laboratory. Dose response curves for percent inhibition were plotted in Microsoft Excel, a best-fitting trendline drawn, and the dose of each compound to inhibit the response (AFC: Antibody Forming Cell/106 splenocytes; AFC spleen: AFC/spleen; ELISA) by 50% (ID50) in rats (R) or mice (M) was visually determined.](/cms/asset/e5fefe41-932e-44f1-ace5-1818f4d102cc/iimt_a_238456_uf0001_b.gif)
TABLE 1 Lowest dose of cyclophosphamide at which statistical significance was observed and percent inhibition
TABLE 2 Cyclophosphamide ID50 values from all four laboratories using the AFC and ELISA assays to evaluate immunosuppression
TABLE 3 Lowest dose of dexamethasone at which statistical significance was observed and percent inhibition
TABLE 4 Dexamethasone ID50 values from all four laboratories using the AFC and ELISA assays to evaluate immunosuppression